{
  "legalName": "INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.",
  "alternateName": "BIOT",
  "ticker": "BIOT",
  "exchange": "Nasdaq",
  "exchangeFullName": "The Nasdaq Stock Market",
  "jurisdiction": "Cayman Islands",
  "listingDate": "2026-07-24",
  "issuerStatus": "Foreign Private Issuer",
  "commissionFileNumber": "001-43415",
  "fiscalYearEnd": "November 30",
  "accountingStandard": "IFRS as issued by the IASB",
  "registeredOffice": {
    "streetAddress": "89 Nexus Way, Camana Bay",
    "addressLocality": "Grand Cayman",
    "postalCode": "KY1-9009",
    "addressCountry": "KY"
  },
  "officialWebsite": "https://instinct-biot.com/",
  "investorRelations": "https://instinct-biot.com/ir",
  "description": "INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (\"BIOT\") is a Cayman Islands-incorporated holding company whose ordinary shares trade on The Nasdaq Stock Market under the ticker symbol BIOT. The group operates businesses originating in Japan across research and development, sourcing, manufacturing, regenerative medicine-related technologies, cosmetics, wellness and consumer brands.",
  "sourcedFacts": [
    {
      "label": "Shares outstanding",
      "value": "28,794,472 ordinary shares",
      "asOf": "July 23, 2026",
      "source": "SEC Form 20-F (shell company report, filed July 29, 2026)",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/2072188/000110465926087649/tm2621369d1_20f.htm"
    },
    {
      "label": "Beneficial ownership — Tomoki Nagano (Chairman & CEO)",
      "value": "10,425,365 ordinary shares (36.21%)",
      "asOf": "July 23, 2026",
      "source": "SEC Form 20-F",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/2072188/000110465926087649/tm2621369d1_20f.htm"
    },
    {
      "label": "Beneficial ownership — Relativity Acquisition Sponsor, LLC",
      "value": "5,515,481 ordinary shares (19.15%)",
      "asOf": "July 23, 2026",
      "source": "SEC Form 20-F",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/2072188/000110465926087649/tm2621369d1_20f.htm"
    },
    {
      "label": "Beneficial ownership — Chardan Capital Markets LLC",
      "value": "1,615,385 ordinary shares (5.61%)",
      "asOf": "July 23, 2026",
      "source": "SEC Form 20-F",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/2072188/000110465926087649/tm2621369d1_20f.htm"
    }
  ],
  "leadership": [
    {
      "name": "Tomoki Nagano",
      "role": "Chairman & CEO"
    },
    {
      "name": "Yuji Naito",
      "role": "Director & COO"
    },
    {
      "name": "Fumihiro Nagano",
      "role": "Director & CMO"
    },
    {
      "name": "Masato Terachi",
      "role": "Independent Director"
    },
    {
      "name": "Say Leong Lim",
      "role": "Independent Director"
    },
    {
      "name": "Sally Lim",
      "role": "Independent Director"
    },
    {
      "name": "Jessica Assaf",
      "role": "Independent Director"
    },
    {
      "name": "Masashi Ohmatsu",
      "role": "Executive Officer & CFO"
    },
    {
      "name": "Futa Sakakibara",
      "role": "Chief Technical Officer"
    },
    {
      "name": "Kenta Nakajima",
      "role": "Executive Officer, Head of Manufacturing (Japan & International)"
    },
    {
      "name": "Takashi Bota",
      "role": "Executive Officer, Head of Sales & Head of Value Athlete Division"
    }
  ],
  "advisors": [
    {
      "name": "Koichiro Maruta, M.D.",
      "role": "Special Advisor, Regenerative Medicine"
    },
    {
      "name": "M. D. Daniel Hadinoto, MD",
      "role": "Medical Advisor (Indonesia)"
    },
    {
      "name": "Akemi Yamaguchi",
      "role": "Femcare Strategy Advisor"
    }
  ],
  "subsidiaries": [
    {
      "name": "INSTINCT BROTHERS",
      "url": "https://instinct-bro.com/"
    },
    {
      "name": "INSTINCT RAS",
      "url": "https://www.instinct-ras.com/"
    },
    {
      "name": "HIROKI GLOBAL",
      "url": "https://hrk-jp.co.jp/"
    },
    {
      "name": "ARTISANS PRODUCTION",
      "url": "https://apjapan.jp/"
    }
  ],
  "authoritativeSources": {
    "secEdgar": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002072188&type=&dateb=&owner=include&count=40",
    "nasdaq": "https://www.nasdaq.com/market-activity/stocks/biot",
    "form20F": "https://www.sec.gov/Archives/edgar/data/2072188/000110465926087649/tm2621369d1_20f.htm",
    "secFilingCenter": "https://instinct-biot.com/ir/sec-filings",
    "factRegistry": "https://instinct-biot.com/ir/facts.json"
  },
  "lastUpdated": "2026-08-08"
}